Key result
CatBoost algorithm predicts 90-day MACE readmissions in blood cancer patients with a ~0.74 ROC-AUC.
Why the study?
Hospitalized patients with blood cancer face an elevated risk for cardiovascular diseases caused by cardiotoxic therapies, which can lead to unplanned readmissions.
Can machine learning models accurately predict 90-day unplanned readmissions for major adverse cardiovascular events in hospitalized patients with blood cancers?
Cohort (n=76,957)
Yes
Can machine learning models accurately predict 90-day unplanned readmissions for major adverse cardiovascular events in hospitalized patients with blood cancers?
Machine learning models, particularly CatBoost, can effectively predict 90-day MACE-related readmissions in hospitalized patients with blood cancers, identifying older age, heart failure, coronary atherosclerosis, and cardiac dysrhythmias as key predictors.
May aid risk stratification in blood cancer inpatients; leaves open external validation before clinical adoption.
BackgroundHospitalized patients with blood cancer face an elevated risk for cardiovascular diseases caused by cardiotoxic cancer therapies, which can lead to cardiovascular-related unplanned readmissions.ObjectiveWe aimed to develop a machine learning (ML) model to predict 90-day unplanned readmissions for major adverse cardiovascular events (MACE) in hospitalized patients with blood cancers.DesignA retrospective population-based cohort study.MethodsWe analyzed patients aged ≥18 with blood cancers (leukemia, lymphoma, myeloma) using the Nationwide Readmissions Database. MACE included acute myocardial infarction, ischemic heart disease, stroke, heart failure, revascularization, malignant arrhythmias, and cardiovascular-related death. Six ML algorithms (L2-Logistic regression, Support Vector Machine, Complement Naïve Bayes, Random Forest, XGBoost, and CatBoost) were trained on 2017-2018 data and tested on 2019 data. The SuperLearner algorithm was used for stacking models. Cost-sensitive learning addressed data imbalance, and hyperparameters were tuned using 5-fold cross-validation with Optuna framework. Performance metrics included the Area Under the Receiver Operating Characteristics Curve (ROCAUC), Precision-Recall AUC (PRAUC), balanced Brier score, and F2 score. SHapley Additive exPlanations (SHAP) values assessed feature importance, and clustering analysis identified high-risk subpopulations.ResultsAmong 76 957 patients, 1031 (1.34%) experienced unplanned 90-day MACE-related readmissions. CatBoost achieved the highest ROCAUC (0.737, 95% CI: 0.712-0.763) and PRAUC (0.040, 95% CI: 0.033-0.050). The SuperLearner algorithm achieved slight improvements in most performance metrics. Four leading predictive features were consistently identified across algorithms, including older age, heart failure, coronary atherosclerosis, and cardiac dysrhythmias. Twenty-three clusters were determined with the highest-risk cluster (mean log odds of 1.41) identified by nonrheumatic/unspecified valve disorders, coronary atherosclerosis, and heart failure.ConclusionsOur ML model effectively predicts MACE-related readmissions in hospitalized patients with blood cancers, highlighting key predictors. Targeted discharge strategies may help reduce readmissions and alleviate the associated healthcare burden.
No takes yet. Share an insight, caveat, or question.
Le et al. (2025) conducted a cohort in Blood cancers (leukemia, lymphoma, multiple myeloma, myelodysplastic syndrome) (n=76,957). Machine learning prediction models (CatBoost) vs. Other machine learning algorithms (Logistic regression, SVM, Naive Bayes, Random Forest, XGBoost) was evaluated on 90-day unplanned MACE hospital readmission prediction (ROC-AUC) (ROC-AUC 0.737, 95% CI 0.712-0.763). The CatBoost machine learning algorithm effectively predicted 90-day unplanned MACE-related readmissions in hospitalized patients with blood cancers, achieving a ROC-AUC of 0.737.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: